The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2021 Jun 2

PMID 34065907

Citations 7

Authors

Zhengying Zhou

Jinwei Zhu

Muhan Jiang

Lan Sang

Kun Hao

Hua He

Affiliations

Soon will be listed here.

Abstract

Human-derived in vitro models can provide high-throughput efficacy and toxicity data without a species gap in drug development. Challenges are still encountered regarding the full utilisation of massive data in clinical settings. The lack of translated methods hinders the reliable prediction of clinical outcomes. Therefore, in this study, in silico models were proposed to tackle these obstacles from in vitro to in vivo translation, and the current major cell culture methods were introduced, such as human-induced pluripotent stem cells (hiPSCs), 3D cells, organoids, and microphysiological systems (MPS). Furthermore, the role and applications of several in silico models were summarised, including the physiologically based pharmacokinetic model (PBPK), pharmacokinetic/pharmacodynamic model (PK/PD), quantitative systems pharmacology model (QSP), and virtual clinical trials. These credible translation cases will provide templates for subsequent in vitro to in vivo translation. We believe that synergising high-quality in vitro data with existing models can better guide drug development and clinical use.

Citing Articles

Stem cell-based approaches for developmental neurotoxicity testing.

Ku J, Asuri P Front Toxicol. 2024; 6:1402630.

PMID: 39238878 PMC: 11374538. DOI: 10.3389/ftox.2024.1402630.

Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients.

Lazzari G, Opattova A, Arena S J Exp Clin Cancer Res. 2024; 43(1):146.

PMID: 38750579 PMC: 11094891. DOI: 10.1186/s13046-024-03065-0.

Translational Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Oxaliplatin and Irinotecan in Colorectal Cancer.

Zhu J, Zhang Y, Zhao Y, Zhang J, Hao K, He H Pharmaceutics. 2023; 15(9).

PMID: 37765243 PMC: 10535808. DOI: 10.3390/pharmaceutics15092274.

Magnetic resonance imaging and ultrasound elastography in the context of preclinical pharmacological research: significance for the 3R principles.

Obrecht M, Zurbruegg S, Accart N, Lambert C, Doelemeyer A, Ledermann B Front Pharmacol. 2023; 14:1177421.

PMID: 37448960 PMC: 10337591. DOI: 10.3389/fphar.2023.1177421.

In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part III.

Witkowski J, Polak S, Pawelec D, Rogulski Z Int J Mol Sci. 2023; 24(3).

PMID: 36768563 PMC: 9917191. DOI: 10.3390/ijms24032239.

References

Pickl M, Ries C . Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene. 2008; 28(3):461-8. DOI: 10.1038/onc.2008.394. View

Guillouzo A, Corlu A, Aninat C, Glaise D, Morel F, Guguen-Guillouzo C . The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem Biol Interact. 2007; 168(1):66-73. DOI: 10.1016/j.cbi.2006.12.003. View

Namekawa T, Ikeda K, Horie-Inoue K, Inoue S . Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells. Cells. 2019; 8(1). PMC: 6357050. DOI: 10.3390/cells8010074. View

Novak R, Ingram M, Marquez S, Das D, Delahanty A, Herland A . Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020; 4(4):407-420. PMC: 8057865. DOI: 10.1038/s41551-019-0497-x. View

Arrowsmith J, Miller P . Trial watch: phase II and phase III attrition rates 2011-2012. Nat Rev Drug Discov. 2013; 12(8):569. DOI: 10.1038/nrd4090. View

Datta D, Vasudevan A . Migration, Chemo-Attraction, and Co-Culture Assays for Human Stem Cell-Derived Endothelial Cells and GABAergic Neurons. J Vis Exp. 2020; (155). PMC: 7182084. DOI: 10.3791/60295. View

Donato M, Lahoz A, Castell J, Gomez-Lechon M . Cell lines: a tool for in vitro drug metabolism studies. Curr Drug Metab. 2008; 9(1):1-11. DOI: 10.2174/138920008783331086. View

Sager J, Yu J, Ragueneau-Majlessi I, Isoherranen N . Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification. Drug Metab Dispos. 2015; 43(11):1823-37. PMC: 4613950. DOI: 10.1124/dmd.115.065920. View

Mrass P, Takano H, Ng L, Daxini S, Lasaro M, Iparraguirre A . Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J Exp Med. 2006; 203(12):2749-61. PMC: 2118164. DOI: 10.1084/jem.20060710. View

10.

Nieuweboer A, de Morree E, de Graan A, Sparreboom A, de Wit R, Mathijssen R . Inter-patient variability in docetaxel pharmacokinetics: A review. Cancer Treat Rev. 2015; 41(7):605-13. DOI: 10.1016/j.ctrv.2015.04.012. View

11.

Boon R, Kumar M, Tricot T, Elia I, Ordovas L, Jacobs F . Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines. Nat Commun. 2020; 11(1):1393. PMC: 7069944. DOI: 10.1038/s41467-020-15058-6. View

12.

Bryl E, Vallejo A, Matteson E, Witkowski J, Weyand C, Goronzy J . Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis. Arthritis Rheum. 2005; 52(10):2996-3003. DOI: 10.1002/art.21353. View

13.

Jain P, Pawar R, Pandey R, Madan J, Pawar S, Lakshmi P . In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?. Biotechnol Adv. 2017; 35(7):889-904. DOI: 10.1016/j.biotechadv.2017.08.003. View

14.

Lin Y, Gil C, Yoder M . Differentiation, Evaluation, and Application of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells. Arterioscler Thromb Vasc Biol. 2017; 37(11):2014-2025. DOI: 10.1161/ATVBAHA.117.309962. View

15.

Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

16.

David L, Dulong V, Le Cerf D, Cazin L, Lamacz M, Vannier J . Hyaluronan hydrogel: an appropriate three-dimensional model for evaluation of anticancer drug sensitivity. Acta Biomater. 2007; 4(2):256-63. DOI: 10.1016/j.actbio.2007.08.012. View

17.

Koning M, van den Berg C, Rabelink T . Stem cell-derived kidney organoids: engineering the vasculature. Cell Mol Life Sci. 2019; 77(12):2257-2273. PMC: 7275011. DOI: 10.1007/s00018-019-03401-0. View

18.

Langhans S . Three-Dimensional Cell Culture Models in Drug Discovery and Drug Repositioning. Front Pharmacol. 2018; 9:6. PMC: 5787088. DOI: 10.3389/fphar.2018.00006. View

19.

Hartmann S, Biliouris K, Lesko L, Nowak-Gottl U, Trame M . Quantitative Systems Pharmacology Model-Based Predictions of Clinical Endpoints to Optimize Warfarin and Rivaroxaban Anti-Thrombosis Therapy. Front Pharmacol. 2020; 11:1041. PMC: 7381140. DOI: 10.3389/fphar.2020.01041. View

20.

Reyner E, Sevidal S, West M, Clouser-Roche A, Freiwald S, Fenner K . In vitro characterization of axitinib interactions with human efflux and hepatic uptake transporters: implications for disposition and drug interactions. Drug Metab Dispos. 2013; 41(8):1575-83. DOI: 10.1124/dmd.113.051193. View